Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Neurobiological Mechanisms of Chess as an Add-On Treatment Against Substance Use Disorder

NCT04057534 is registered in ClinicalTrials.gov with Central Institute of Mental Health, Mannheim as lead sponsor.

NCT NCT04057534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04057534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Neurobiological Mechanisms of Chess as an Add-On Treatment Against Substance Use Disorder
Lead sponsor
Central Institute of Mental Health, Mannheim
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2020
Completion date
November 17, 2023
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

substance use disorders